About the Rare Cancers Session
While rare cancers individually affect fewer people, collectively they pose a significant health challenge. Due to their infrequency, research and resources are often limited compared to more common cancers. However, understanding and treating rare cancers are crucial for advancing oncology as a whole. Innovative approaches such as precision medicine, which tailors treatments to individuals based on genetic makeup, are showing promise in addressing rare cancers. Collaboration among researchers, clinicians, and patients is key to driving progress in this field. Moreover, initiatives to increase awareness, funding, and clinical trials specific to rare cancers are essential for improving diagnosis and treatment outcomes. By focusing efforts on these less common but equally critical cancers, we can broaden our understanding of cancer biology and ultimately improve patient care and survival rates.
Topics Covered in Rare Cancers
Diagnostic Delays
Expert Pathology Review
Tumor-Agnostic Therapy
Basket Trial Design
Patient Registries
Orphan Drug Development
Related Scientific Sessions at CIOC 2027
Why Attend the Rare Cancers Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Rare Cancers work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Rare Cancers research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Rare Cancers track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Rare Cancers Conference 2027 — FAQs
What is the Rare Cancers track at CIOC 2027?
The Rare Cancers track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Rare Cancers. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Rare Cancers sessions?
Cancer researchers and clinicians, educators and students with an interest in Rare Cancers are all welcome — whether presenting or attending.
Can I present my research in the Rare Cancers track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Rare Cancers sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Rare Cancers track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.